<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03909230</url>
  </required_header>
  <id_info>
    <org_study_id>NCV-VIS-001</org_study_id>
    <nct_id>NCT03909230</nct_id>
  </id_info>
  <brief_title>Endometrial Fluid Study in Natural Cycles: a Prospective Observational Study</brief_title>
  <official_title>Endometrial Fluid Study in Natural Cycles: a Prospective Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Anecova SA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Anecova SA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to collect information about the characteristics of endometrial fluid
      at day 2 and day 4 post-ovulation in normal fertile women.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Implantation rates have stabilised around 35% in IVF and a current key rate limiting step is
      achieving successful implantation of the embryo. 1/3 of implantation failures are estimated
      to be caused by a problem with the receptivity of the endometrium. In recent years, several
      measurable parameters have been reported to assess endometrial receptivity. However, one
      parameter remains undescribed, the endometrial fluid viscosity.

      It is generally believed that the viscosity change post ovulation is influenced by the luteal
      phase endocrine milieu, and it is possible that the viscosity of the endometrial fluid has an
      impact on implantation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2, 2019</start_date>
  <completion_date type="Actual">May 31, 2019</completion_date>
  <primary_completion_date type="Actual">May 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Viscosity of endometrial fluid at D2 and D4 post ovulation of the normal cycle, respectively</measure>
    <time_frame>4 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma progesterone level</measure>
    <time_frame>4 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma estradiol (E2) level</measure>
    <time_frame>4 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endometrial thickness as measured by ultrasound</measure>
    <time_frame>4 days</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Endometrial Fluid</condition>
  <arm_group>
    <arm_group_label>Day 2 post ovulation</arm_group_label>
    <description>Ultrasound of the endometrium, Endometrial fluid sample, Blood sample</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Day 4 post ovulation</arm_group_label>
    <description>Ultrasound of the endometrium, Endometrial fluid sample, Blood sample</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Women eligible and qualified as egg donors at IVIRMA Bilbao that meets the inclusion
        criteria
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age: â‰¤ 35 years

          -  Women eligible and qualified for egg donation at IVIRMA Bilbao

          -  Proven fertile (having given birth to at least one spontaneously conceived normal
             child)

          -  Signed written consent including sharing of anonymized data

        Exclusion Criteria:

          -  Contraindications for egg donation according to IVIRMA Bilbao guidelines
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>IVIRMA Bilbao</name>
      <address>
        <city>Leioa</city>
        <state>Vizcaya</state>
        <zip>48940</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 2, 2019</study_first_submitted>
  <study_first_submitted_qc>April 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 9, 2019</study_first_posted>
  <last_update_submitted>July 2, 2019</last_update_submitted>
  <last_update_submitted_qc>July 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

